Business
The Overlooked Bottleneck in Cell Therapy: Reliable Access to High-Quality Biological Material
Today, cell and gene therapies are changing the outlook for some patients with leukemia, lymphoma, sickle cell disease, inherited immune disorders and other serious conditions. More therapies are advancing through ...